Skip to main content

Table 3 Treatment outcomes according to line of therapy

From: A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

Line of systemic therapy

Patients receiving therapy, n

Clinician-documented response, n (%)

Treatment duration, months, mean (SD)

Time from initiation of previous therapy to current therapy, months, mean (SD)

First-line

99

19 (18.8)

6.0 (7.4)

N/A

Second-line

99

15 (15.2)

5.4 (5.3)

12.3 (13.4)

Third-line

78

8 (11.1)

4.1 (4.2)

9.9 (12.1)

Fourth-line

49

5 (11.4)

5.3 (9.1)

6.2 (5.6)

Fifth-line

35

4 (12.5)

4.2 (5.2)

5.0 (3.6)

Sixth-line

20

2 (11.1)

3.2 (3.7)

7.3 (7.4)

Seventh-line

15

1 (7.7)

1.7 (1.1)

5.7 (6.0)

Eighth-line

7

1 (16.7)

4.1 (3.3)

5.7 (6.5)

Ninth-line

6

0 (0.0)

2.2 (2.2)

7.9 (9.6)

Tenth-line

2

0 (0.0)

3.9 (5.0)

4.4 (1.6)

Most recent therapy

99

13 (12.9)

3.6 (6.3)

8.7 (9.6)

  1. Abbreviations: N/A not available; SD standard deviation.